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Articulated rods -a novel class of molecular rods based on oligospiroketals (OSK)
]heneicosane 3-carboxylate (7)
3.9 g (14.1 mmol) of ketone 5 were suspended in 450 mL dry Et 2 O and cooled to 0°C. After addition of 564 mg (14,10 mmol) NaH (60 % content) and 1.8 mL (14.10 mmol) TMSCl the suspension was stirred for 1h at r.t. Then, 5.24 g (14. 10 mmol) of diol 6 und one drop TMSOTf were added and the mixture was stirred over night. The precipitated product 7 was filtered off to give 6.87 g (10.90 7.19 (d, 3 J = 9 Hz, 2H, H-10); 13 C-NMR (75.5 MHz, CDCl 3 , ppm): δ 0.1 (C-1), 31.7 (C-2), 33.5 (C-11), 33.9
(C-2), 39.0 (C-3) , 41.2 (C-3), 42.1 (C-3), 54.1 (C-8), 55.6 (C-5), 63.8 (C-4), 69.6 (C-6), 73.2 (C-7), 91.9 (C-12), 97.3 (C-13), 100.3 (C-14), 114.2 (C-10), 129.7 (C-15), 130.0 (C-9), 154.7 (C-16), 159.8 (C-17), 168.0 (C-17); m.p. 96-100 °C; IR: 2959 IR: , 2866 IR: , 2183 IR: , 1706 IR: , 1653 IR: , 1610 IR: , 1511 IR: , 1468 IR: , 1437 IR: , 1360 IR: , 1345 IR: , 1248 IR: , 1228 IR: , 1095 IR: , 1036 ]heneicosan-3-carboxylate (8) 5 .20 g (8.56 mmol) 7 and 9.72 g (42.80 mmol) DDQ were dissolved in 840 mL of a mixture of DCM/pH7 buffer (9:1) and stirred over night. A black aqueous and a red organic phase are formed.
The phases were separated and the aqueous phase was extracted with 150 mL DCM. The combined organic phases were washed twice with 200 mL sat. aqueous NaHCO 3 solution and then with brine.
After drying and evaporating a red oil was obtained, which purified by FC (DCM/MeOH 100:2). 3.89 g (7.62 mmol, 89%) 8 were obtained. Rf (DCM/MeOH 100/4) = 0.29; 1 H-NMR (300 MHz, CDCl 3 , ppm): δ 0.16 (s, 9H, H-1), 1.61 (m, 8H, H-2) , 3.32 (m, 2H, H-3) , 3.49 (m, 4H, H-3) , 3.65 (m, 2H, H-3) , 3.78 (m, 8H, H-4) , 4.14 (s, 2H, H-5), 4.68 (s, 2H, H-6); 13 C-NMR (75.5 MHz, CDCl 3 , ppm): δ -0.3 (C-1), 31.1 (C-2), 33.2 (C-7), 39.2 (C-3) , 40.1 (C-3), 40.8 (C-3), 53.7 (C-6), 59.7 (C-5), 63.5 (C-4), 91.6 (C-8), 97.0 (C-9), 99.9 (C-10), 154.3 (C-11), 169.9 (C-12) ; Fp = 169-171 °C; IR: 2961 IR: , 2862 IR: , 2190 IR: , 1701 IR: , 1637 IR: , 1483 IR: , 1469 IR: , 1423 IR: , 1364 IR: , 1347 IR: , 1251 IR: , 1228 IR: , 1090 IR: , 1039 (C-1), 31.0 (C-2), 33.1 (C-7), 33.5 (C-2), 38.9 (C-3) , 40.7 (C-3), 41.8 (C-3), 50.7 (C-5), 53.7 (C-6), 63.4
(C-4), 91.5 (C-8), 96.6 (C-9) , 99.9 (C-10), 154.3 (C-11), 169.4 (C-12); m.p. 47-50 °C; IR: 2963 IR: , 2870 IR: , 2183 IR: , 2106 IR: , 1701 IR: , 1657 IR: , 1438 IR: , 1359 IR: , 1231 IR: , 1094 IR: , 1037 96.6 (C-10), 96.9 (C-10), 154.2 (C-11), 169.8 (C-12); m.p. 151 IR: 2959 IR: , 2869 IR: , 2119 IR: , 1698 IR: , 1630 IR: , S8 1471 IR: , 1440 IR: , 1381 IR: , 1362 IR: , 1269 IR: , 1232 IR: , 1164 IR: , 1096 5 (C-8), 143.6 (C-13), 154.3 (C-14), 154.8 (C-15), 163.0 (C-16), 169.8 (C-17); m.p. 127-128 °C; IR: 2962 IR: , 2866 IR: , 2183 IR: , 1697 IR: , 1653 IR: , 1470 IR: ,1440 IR: , 1363 IR: , 1344 IR: , 1269 IR: , 1231 IR: , 1095 IR: , 1037 (C-11), 96.3 (C-12) , 96.5 (C-12), 96.7 (C-12), 125.3 (C-9) , 143. 
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m.p. 115-120 °C; IR: 2968 IR: , 2777 IR: , 2106 IR: , 1698 IR: , 1537 IR: , 1468 IR: , 1439 IR: , 1363 IR: , 1231 IR: , 1198 IR: , 1094 IR: , 1037 217-220 °C; IR: 2966 IR: , 2870 IR: , 2245 IR: , 1697 IR: , 1656 IR: , 1471 IR: ,1440 IR: , 1363 IR: , 1342 IR: , 1269 IR: , 1232 IR: , 1095 
1-{(2S)-2-[(4-Methoxybenzyl)oxy]-4-methylpentanoyl]piperidin-4-one (18)
33 mL dry DCM were cooled to -60°C. 810 µL (11.40 mmol) dry DMSO and 1.49 mL (8.56 mmol)
oxalylchloride were successively added drop-wise. The mixture was stirred for 30 min and then 1.91 g (5.70 mmol) 17, dissolved in 3.5 mL dry DCM, were slowly added drop-wise. After 30 min stirring 4.12 mL (28.50 mmol) dry Et 3 N were added and the mixture was allowed to warm up to r. : 2958, 2868, 1704, 1636, 1512, 1467, 1438, 1362, 1248, 1231, 1095, 1035 2959, 2875, 1703, 1640, 1468, 1438, 1363, 1249, 1230, 1142, 1095, 1038, 844 : 2961, 2870, 2107, 1703, 1650, 1468, 1439, 1363, 1249, 1230, 1140, 1094, 1038 IR: 3448, 2960 IR: 3448, , 2870 IR: 3448, , 2105 IR: 3448, , 1699 IR: 3448, , 1653 IR: 3448, , 1469 IR: 3448, , 1439 IR: 3448, , 1363 IR: 3448, , 1231 IR: 3448, , 1166 IR: 3448, , 1141 IR: 3448, , 1094 IR: 3448, , 1039 : 3457, 2960, 2870, 1703, 1642, 1469, 1439, 1363, 1273, 1232, 1166, 1142, 1094, 1041, 940, 892, 847, 796, 763, 730 2961, 2870, 2104, 1699, 1655, 1468, 1440, 1363, 1272, 1231, 1198, 1140, 1093, 1042, 940, 892, 795, 762 
1-(4-Hydroxypiperidin-1-yl)-2-(pyren-1-yl)ethanone (pre-27a)
1,42 g (5.44 mmol) Pyrene-1-yl acetic acid, 500 mg (4.94 mmol) 4-hydroxypiperidine and 735 mg (5.44 mmol) HOBT were dissolved in 11 mL dry THF. After 30min stirring 1.12 g (5.44 mmol) DCC were added and the mixture was stirred over night. The precipitate (dicyclohexyl urea) was filtered
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off and washed with EE. The combined organic solutions were evaporated, dissolved in 13 mL EE and washed successively with 10 mL 0,01M HCl, 10 mL sat. NaHCO 3 and 10 mL brine. After drying with 
1-(Pyren-1-ylacetyl)piperidin-4-one (27a)
824 mg (2.4 mmol) pre-27a were dissolved in 50 mL dry DCM. The solution was cooled with an ice bath and 137 mg (3.1 mmol) DMP were added slowly. After 30min a white precipitate is formed.
After additional stirring at r. 342.1489, found 342.1491.
(2E)-1-(4-Hydroxypiperidin-1-yl)-3-phenylprop-2-en-1-one (pre-27b)
1 g (9,89 mmol) 4-Hydroxypiperidine and 1.73 mL (10,2 mmol) DIEA were dissolved in 20 mL DCM and cooled to 0°C. 1.42 mL (9,89 mmol) cinnamoyl chloride were added drop-wise and the mixture was stirred at r.t. over night. 10 mL 0.02 M HCL were added, the phases were separated and the organic phase was dried with MgSO 4 and evaporated. 
1-[(2E)-3-Phenylprop-2-enoyl]piperidin-4-one (27b)
1,6 g (6.90 mmol) pre-27b were dissolved in 140 mL dry DCM. After cooling to 0°C 1458, 1438, 1357, 1273, 1258, 1229, 1192, 1093, 977, 765 ; IR: 3276, 2962 IR: 3276, , 2883 IR: 3276, , 2128 IR: 3276, , 1706 IR: 3276, , 1468 IR: 3276, , 1417 IR: 3276, , 1356 IR: 3276, , 1269 IR: 3276, , 1225 IR: 3276, , 1137 IR: 3276, , 1056 115-116 °C; IR: 3249, 2934 IR: 3249, , 2868 IR: 3249, , 1702 IR: 3249, , 1640 IR: 3249, , 1438 IR: 3249, , 1361 IR: 3249, , 1230 IR: 3249, , 1093 3246, 2937, 2869, 1699, 1645, 1604, 1438, 1362, 1231, 1199, 1165, 1094, 1037, 976, 940, 894 IR: 3289, 2966 IR: 3289, , 2869 IR: 3289, , 1700 IR: 3289, , 1649 IR: 3289, , 1469 IR: 3289, , 1439 IR: 3289, , 1363 IR: 3289, , 1275 IR: 3289, , 1231 IR: 3289, , 1199 IR: 3289, , 1166 IR: 3289, , 1143 IR: 3289, , 1094 IR: 3289, , 1036 2867, 2104, 1645, 1440, 1362, 1245, 1221, 1165, 1144, 1090, 1036, 940, 908, 888, 847, 796 4-82.8 °C; IR: 2934 IR: , 2869 IR: , 2105 IR: , 1645 IR: , 1603 IR: , 1438 IR: , 1362 IR: , 1219 IR: , 1165 IR: , 1144 IR: , 1090 IR: , 1060 IR: , 1036 3.35 (m, 2H, H-2), 3.47 (m, 2H, H-2), 3.58 (m, 4H, H-2), 3.69 (m, 4H, H-3), 3.76 (m, 4H, H-3), 3.91 (s, 2H, H-4) , 4.04 (s, 2H, H-5); ; IR: 2966 IR: , 2871 IR: , 2106 IR: , 1649 IR: , 1443 IR: , 1363 IR: , 1266 IR: , 1223 IR: , 1198 IR: , 1165 IR: , 1147 IR: , 1091 IR: , 1036 3 (C-11), 154.6 (C-12), 162.8 (C-13), 169.2 (C-14); m.p. 199.8-210 °C; IR: 3041, 2962 IR: 3041, , 2868 IR: 3041, , 1696 IR: 3041, , 1644 IR: 3041, , 1467 IR: 3041, , 1439 IR: 3041, , 1362 IR: 3041, , 1233 IR: 3041, , 1198 IR: 3041, , 1165 IR: 3041, , 1143 IR: 3041, , 1093 IR: 3041, , 1037 166.8-172 °C; IR: 2962 IR: , 2868 IR: , 1696 IR: , 1645 IR: , 1601 IR: , 1468 IR: , 1438 IR: , 1363 IR: , 1230 IR: , 1199 IR: , 1165 IR: , 1143 IR: , 1090 126-129 °C; IR: 2965 IR: , 2870 IR: , 1694 IR: , 1649 IR: , 1469 IR: , 1442 IR: , 1363 IR: , 1231 IR: , 1198 IR: , 1165 IR: , 1145 IR: , 1091 IR: , 1035 1664, 1576, 1446, 1363, 1229, 1312, 1230, 1199, 1166, 1093, 940, 888, 767, 729 m.p. 148-153 °C; IR: 2933 IR: , 2868 IR: , 1740 IR: , 1694 IR: , 1663 IR: , 1443 IR: , 1362 IR: , 1230 IR: , 1198 IR: , 1163 IR: , 1092 
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Irradiation spectra
Compounds 32b, 33a, 39 were irradiated in ACN. 1; 6; 27; 67; 127; 157; 217; 337; 517 min Fluorescence intensities at 377 nm in the presence of KJ were related to that in the absence of KJ.
Spectra of the rod in DOPC MLVs
MD simulation
The MD simulation was performed with the program MOE 2010.10 (Chemical Comuting Group) using the MMFF94x forcefield [5] at 600 K. For using MD simulations to evaluate the rigidity of molecular rods see [6] .
End-to-End distance distribution of a model articulated rod ( 
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Materials and Methods
Materials
1,2-Dioleoyl-sn-glycero-3-phosphocholine (DOPC) was purchased from Avanti Polar Lipids (Alabaster, AL). HEPES buffered salt solution (HBS) contained 10 mM HEPES and 145 mM NaCl, pH 7.4.
Preparation of multilamellar vesicles (MLVs)
Aliquots of DOPC (from a stock solution in chloroform and methanol) and 32a (from a stock solution in methanol) were transferred to a glass tube and resuspended in HBS to give a final lipid concentration of 0.5 mM and different rod concentrations. The suspensions were vigorously vortexed resulting in the formation of MLVs.
Fluorescence spectroscopy
Fluorescence spectra were recorded at an Aminco Bowman 2 fluorescence spectrophotometer (Thermo electron corporation, Langenselbold, Germany).
